ISMAEL LARES ASSEFF



DATOS GENERALES
Nombre completo   ISMAEL LARES ASSEFF
Máximo nivel de estudios   DOCTORADO
Antigüedad académica en la UNAM   años, meses, días
NOMBRAMIENTOS
Último 
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
* SNI I2010 - 2023

INFORMACIÓN DE PUBLICACIONES
Firmas  
Asseff I.L. Lares Asseff I. Lares I. Lares-Asef I. Lares-Aseff I. Lares-Aseff I.A.
Lares-Asseff I. Lares-Asseff I.A. Lares-Asseff, I.
ID's SCOPUS  
7004266592
Áreas de conocimiento  
Agriculture, multidisciplinary Biology Biotechnology and applied microbiology Chemistry, analytical Endocrinology and metabolism
Geriatrics and gerontology Medicine, general & internal Medicine, general and internal Medicine, research & experimental Nutrition & dietetics
Pediatrics Pharmacology & pharmacy Pharmacology and pharmacy Public, environmental and occupational health Agricultural and Biological Sciences (miscellaneous)
Analytical Chemistry Biochemistry (medical) Environmental Science (miscellaneous) Internal Medicine Medicine (miscellaneous)
Pediatrics, Perinatology and Child Health Pharmacology Pharmacology (medical) Pharmacology, Toxicology and Pharmaceutics (miscellaneous) Pollution
Coautorías con entidades de la UNAM  
Revistas en las que ha publicado  (41):
  1. Acta Pediatrica Espanola, España (1995)
  2. Agrociencia, México (2013, 2015)
  3. AMERICAN JOURNAL OF CLINICAL NUTRITION, Estados Unidos America (1980, 1999)
  4. ANN PHARMACOTHER, Estados Unidos America (1994, 2000)
  5. Archives Of Medical Research, México (1996, 1998)
  6. BIOLOGICAL & PHARMACEUTICAL BULLETIN, Japón (2004)
  7. BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, México (1987, 1988, 2013, 2014)
  8. CLIN PHARMACOL THER, Estados Unidos America (1992)
  9. Chromatographia, Alemania (2004)
  10. CHRONOBIOLOGY INTERNATIONAL, Estados Unidos America (2003)
  11. DIABETES-METABOLISM RESEARCH AND REVIEWS, Reino Unido (2013)
  12. DISEASE MARKERS, Países Bajos (2014)
  13. DRUG DEVELOPMENT RESEARCH, Estados Unidos America ()
  14. Drug Metabolism and Drug Interactions, Alemania (2012, 2013)
  15. Drug Metabolism and Personalized Therapy, Alemania (2015, 2016)
  16. EARLY HUMAN DEVELOPMENT, Irlanda (2014)
  17. ETHNIC DIS, Estados Unidos America (2012)
  18. FRONTIERS IN PHARMACOLOGY, Suiza (2016)
  19. GACETA MEDICA DE MEXICO, México (1986, 2001, 2015)
  20. HONG KONG J PAEDIATR, China (2017)
  21. INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, Suiza (1995)
  22. INTERNATIONAL JOURNAL OF PHARMACOLOGY, Pakistán (2015)
  23. JOURNAL OF CLINICAL PHARMACOLOGY, Estados Unidos America (1997, 2006)
  24. JOURNAL OF CHROMATOGRAPHIC SCIENCE, Estados Unidos America (2010)
  25. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, Canada (2001)
  26. JOURNAL OF PHARMACY AND PHARMACOLOGY, Estados Unidos America (2003)
  27. MECHANISMS OF AGEING AND DEVELOPMENT, Irlanda (2006)
  28. Mutation Research/environmental Mutagenesis And Related Subjects, (1996)
  29. Mutation Research/genetic Toxicology, (1993, 1996)
  30. NEUROPSYCHOPHARMACOLOGY, Reino Unido (2000)
  31. PEDIATRIC INFECTIOUS DISEASE JOURNAL, Estados Unidos America (2016)
  32. PHARMACOGENOMICS JOURNAL, Reino Unido (2011)
  33. Pharmacology, Suiza (2010)
  34. Proceedings of the Western Pharmacology Society, Estados Unidos America (1998, 2002, 2005)
  35. Revista Cubana De Higiene Y Epidemiologia, (2010)
  36. REVISTA DE BIOLOGIA TROPICAL, Costa Rica (2016)
  37. REVISTA DE GASTROENTEROLOGIA DE MEXICO, México (1999)
  38. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, México (1998, 1999, 2004)
  39. SCAND J INFECT DIS, Noruega (1993)
  40. TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY, Reino Unido (2009)
  41. VITAE-COLUMBIA, Colombia (2015)


Descargar PDF

Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Revista Fuente Citas WoS Citas Scopus
1Nutritional state of Mexican children younger than five years from Mennonite community, Mestiza population of urban and the rural areas from Durango, Mexico1ᵉʳ autor: Lares-Asseff, I., Manriquez-Medina, M., Torres-Monreal, J.A., Solis-Calderón, I., et al.2017HONG KONG J PAEDIATRScopus-id: 2-s2.0-85018847014
02
2Population pharmacokinetics of gentamicin in Mexican children with severe malnutrition1ᵉʳ autor: Lares-Asseff, I., Pérz-Guillé, M.G., Vieyra, G.A.C., Pérez, A.G., et al.2016PEDIATRIC INFECTIOUS DISEASE JOURNALWoS-id: 000380755000015
Scopus-id: 2-s2.0-84979641508
68
3Genetic polymorphisms associated to folate transport as predictors of increased risk for acute lymphoblastic leukemia in Mexican children2ᵒ autor: Lares-Asseff, I., Zaruma-Torres, F., Lima, A., Reyes-Espinoza, A., et al.2016FRONTIERS IN PHARMACOLOGYWoS-id: 000380879200001
Scopus-id: 2-s2.0-84988893707
56
4Involvement of MTHFR and TPMT genes in susceptibility to childhood acute lymphoblastic leukemia (ALL) in Mexicans2ᵒ autor: Lares-Asseff I., Gutiérrez-Álvarez O., Galaviz-Hernández C., Reyes-Espinoza E.-A., et al.2016Drug Metabolism and Personalized TherapyScopus-id: 2-s2.0-84960879765
013
5Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican populationCoautor: Lares-Aseff I., Céspedes-Garro C., Rodrigues-Soares F., Jiménez-Arce G., et al.2016REVISTA DE BIOLOGIA TROPICALScopus-id: 2-s2.0-84978983285
011
6Long-term effects of mesocaval shunt on the pharmacokinetic parameters of metronidazole in lewis ratsCoautor: Lares-Asseff I., Pérez-Guillé B.E., Villegas-Alvarez F., Jimenez-Bravo M.A., et al.2015INTERNATIONAL JOURNAL OF PHARMACOLOGYWoS-id: 000351019600008
Scopus-id: 2-s2.0-84922987410
11
7Relation of leptin in plasma with oxidative damage in indigenous Tepehuán and Mestizo populations from Durango [Relación de la leptina en plasma con el daño oxidativo en poblaciones indígena tepehuana y mestiza de Durango]Coautor: Lares-Aseff I., Delgadillo-Guzmán D., Quintanar-Escorza M.A., Carrera-Gracia M.A.2015GACETA MEDICA DE MEXICOWoS-id: 000354601600011
Scopus-id: 2-s2.0-84930958694
22
8Pharmacology for the fetus and the newbornCoautor y autor de correspondencia: Lares-Asseff I., Juárez-Olguín H., Buendía-Soto E.2015GACETA MEDICA DE MEXICOWoS-id: 000357016500014
Scopus-id: 2-s2.0-84939807669
47
9Association of ABCB1, ABCC5 and xanthine oxidase genetic polymorphisms with methotrexate adverse reactions in Mexican pediatric patients with ALL2ᵒ autor: Lares-Asseff I., Zaruma-Torres F., Reyes-Espinoza A., Loera-Castañeda V., et al.2015Drug Metabolism and Personalized TherapyScopus-id: 2-s2.0-84941060132
011
10Association of IGF-1 content with whole, reduced-fat, and low-fat milk in México [Asociación del contenido del factor de crecimiento insulínico tipo 1 con leche entera, semi-descremada y descremada en México]Coautor: Lares-Asseff I.A., Marín-Quiroga A., Villanueva-Fierro I., Rodríguez-Pérez M.A., et al.2015AgrocienciaScopus-id: 2-s2.0-84929314742
03
11Impacto de polimorfismos genéticos de la vía metabólica del metotrexato sobre la sobrevida de niños Mexicanos con leucemia linfoblástica aguda (LLA)2ᵒ autor: Lares-Asseff I., Zaruma-Torres F., Reyes-Espinoza A., Loera-Castañeda V., et al.2015VITAE-COLUMBIAScopus-id: 2-s2.0-84964940296
01
12Leptin Levels and Nutritional Status of Indigenous Tepehuan and Mestizo Subjects in Durango, MexicoCoautor: Asseff I.L., Guzman, DD, Marchau, LAM, Reyes J.L., et al.2014DISEASE MARKERSWoS-id: 000334595400001
Scopus-id: 2-s2.0-84900027029
43
13Association of the intronic polymorphism rs12540874 A > G of the GRB10 gene with high birth weightCoautor: Lares-Aseff I.A., González-Renteria S.M., Sosa-Macías M., Rodríguez-Moran M., et al.2014EARLY HUMAN DEVELOPMENTWoS-id: 000343379300001
Scopus-id: 2-s2.0-84922336248
88
14Laparoscopic cholecystectomy in a patient with ventriculoperitoneal shunt system [Colecistectomía laparoscópica en un paciente con sistema de derivación ventriculoperitoneal]Coautor y autor de correspondencia: Lares-Asseff I., García W.E.H., Ramírez J.P.V.2014BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICOScopus-id: 2-s2.0-84934764156
02
15Association of the polymorphisms 292 C > T and 1304 G > A in the SLC38A4 gene with hyperglycaemiaCoautor: Lares-Aseff I., González-Renteria S.M., Loera-Castañeda V., Chairez-Hernández I., et al.2013DIABETES-METABOLISM RESEARCH AND REVIEWSWoS-id: 000313546000007
Scopus-id: 2-s2.0-84872254060
89
16Evaluation of drug-metabolizing enzyme hydroxylation phenotypes in Hispanic populations: The CEIBA cocktailCoautor: Lares-Aseff I., De Andrés F., Sosa-Macías M., Lazalde-Ramos B.P., et al.2013Drug Metabolism and Drug InteractionsScopus-id: 2-s2.0-84888082961
014
17Avenanthramides and nutritional components of four Mexican oat (Avena sativa L.) varieties [Avenantramidas y componentes nutricionales de cuatro variedades Mexicanas de avena (Avena sativa L.)]Coautor: Lares-Asef I., Ortiz-Robledo F., Villanueva-Fierro I., Dave Oomah B., et al.2013AgrocienciaScopus-id: 2-s2.0-84878356294
09
18Importance of upper gastrointestinal series in children with gastroesophageal reflux [Importancia de la serie esofagogastroduodenal en niños con reflujo gastroesofágico]2ᵒ autor y autor de correspondencia: Lares-Asseff I., García W.E.H.2013BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICOScopus-id: 2-s2.0-84885969155
01
19Biochemical differences in ethnic groups in Durango, Mexico1ᵉʳ autor: Lares-Asseff I., Luján-García A., Sosa-Macías M., Lazalde-Ramos B., et al.2012ETHNIC DISWoS-id: 000322604500017
Scopus-id: 2-s2.0-84861682080
22
20Pharmacogenetics in Latin American populations: Regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disordersCoautor: Lares I., Rodeiro I., Remírez-Figueredo D., García-Mesa M., et al.2012Drug Metabolism and Drug InteractionsScopus-id: 2-s2.0-84860531136
016
21CYP2C9 allele frequency differences between populations of Mexican- Mestizo, Mexican- Tepehuano, and SpaniardsCoautor: Lares-Asseff I., Dorado P., Sosa-Macias M.G., Penas-LLedo, EM, et al.2011PHARMACOGENOMICS JOURNALWoS-id: 000288849900004
Scopus-id: 2-s2.0-79953059565
2940
22Influence of CYP2D6 Deletion, Multiplication,-1584C -> G, 31G -> A and 2988G -> A Gene Polymorphisms on Dextromethorphan Metabolism among Mexican Tepehuanos and MestizosCoautor: Lares-Asseff I., Sosa-Macías M., Dorado P., Alanis-Bañuelos R.E., et al.2010PharmacologyWoS-id: 000280684100005
Scopus-id: 2-s2.0-77953947158
2134
23HPLC Method for Quantification of Oxidative Stress by Salicilate Hydroxylation in Human Plasma2ᵒ autor: Lares-Asseff I., Lazalde-Ramos B.P., Villanueva-Fierro I., Sosa-Macías M., et al.2010JOURNAL OF CHROMATOGRAPHIC SCIENCEWoS-id: 000281047400011
Scopus-id: 2-s2.0-77958009444
44
24Morbidity and mortality from cancer: Experience of the State Center of Cancer from the SSA of Durango state, Mexico [Morbilidad y mortalidad por cáncer: Experiencia del Centro Estatal de Cancerología de la SSA del Estado de Durango, Méxic1ᵉʳ autor: Lares-Asseff I., García-Hernández F., Sosa-Macías M., Loera-Castañeda V., et al.2010Revista Cubana De Higiene Y EpidemiologiaScopus-id: 2-s2.0-79952685713
00
25Effects of ozone exposure on the oxidative capacity for drug biotransformation in Wistar rats1ᵉʳ autor: Lares-Asseff I., Fernandez Saavedra G., Toledo A., Sosa Macís M., et al.2009TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRYScopus-id: 2-s2.0-70449382114
00
26Changes in acetylator phenotype over the lifespan in the Wistar rat1ᵉʳ autor: Lares-Asseff I., Camacho G.A., Guillé A.J., Toledo A.R., et al.2006MECHANISMS OF AGEING AND DEVELOPMENTWoS-id: 000234643900010
Scopus-id: 2-s2.0-28244486119
55
27CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, MexicoCoautor: Lares-Asseff I., Sosa-Macías M., Elizondo G., Flores-Pérez C., et al.2006JOURNAL OF CLINICAL PHARMACOLOGYWoS-id: 000237059000004
Scopus-id: 2-s2.0-33645787537
2836
28Effects of mesocaval shunt on the pharmacokinetics of metronidazole in young ratsCoautor: Lares-Asseff I., Pérez Guillé B.E., Alvarez F.V., Toledo López A.R., et al.2005Proceedings of the Western Pharmacology SocietyWoS-id: 000235514200014
Scopus-id: 2-s2.0-30144446090
11
29Effect of age on the pharmacokinetics of ranitidine in healthy Mexican volunteersCoautor: Lares-Asseff I., Pérez-Guillé G., Guillé-Pérez A., Toledo-López A., et al.2005Proceedings of the Western Pharmacology SocietyWoS-id: 000235514200018
Scopus-id: 2-s2.0-30144444697
56
30Pharmacokinetics of digoxin in children with congestive health failure aggravated by other diseases1ᵉʳ autor: Lares-Asseff I., Juárez-Olguín H., Flores-Pérez J., Bobadilla-Chávez J.2004REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATIONWoS-id: 000221071600006
Scopus-id: 2-s2.0-2342424420
11
31Pharmacokinetics and metabolic rates of acetyl salicylic acid and its metabolites in an Otomi ethnic group of Mexico1ᵉʳ autor: Lares-Asseff I., Juárez-Olguín H., Flores-Pérez J., Guillé-Pérez A., et al.2004BIOLOGICAL & PHARMACEUTICAL BULLETINScopus-id: 2-s2.0-16644385289
712
32Determination of dextromethorphan and dextrorphan in human urine by high performance liquid chromatography for pharmacogenetic investigationsCoautor: Lares-Asseff I., Flores-Pérez J., Flores-?erez C., Juárez-Olguín H., et al.2004ChromatographiaScopus-id: 2-s2.0-2442606407
08
33Effect of severe protein-calorie malnutrition on the penetration kinetics of trimethoprim and sulfamethoxazole to the deep tissues of Wistar rats1ᵉʳ autor: Lares-Asseff I., Pérez M.G., Camacho G.A., Toledo A.R., et al.2003JOURNAL OF PHARMACY AND PHARMACOLOGYWoS-id: 000183281600007
Scopus-id: 2-s2.0-0038738016
13
34Effects of gender and phase of the menstrual cycle on the kinetics of ranitidine in healthy volunteersCoautor: Lares Asseff I., Flores Pérez J., Juàrez Olguín H., Flores Pérez C., et al.2003CHRONOBIOLOGY INTERNATIONALScopus-id: 2-s2.0-0038007197
021
35Bioavailability of ranitidine in healthy Mexican volunteers: Effect of foodCoautor: Lares I., Juárez-Olguín H., Flores J., Pérez G., et al.2002Proceedings of the Western Pharmacology SocietyWoS-id: 000179347100059
Scopus-id: 2-s2.0-1842844223
22
36Patterns of drug consumption in relation with the pathologies of elderly Mexican subjects resident in nursing homesCoautor: Lares-Asseff I., Pérez-Guillé G., Camacho-Vieyra A., Toledo-López A., et al.2001JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCESWoS-id: 000170505700004
Scopus-id: 2-s2.0-0035735288
102
37Pharmacogenetics & its clinical significance [La farmacogenética y su importancia en la clínica]1ᵉʳ autor: Lares-Asseff I., Trujillo-Jiménez F.2001GACETA MEDICA DE MEXICOScopus-id: 2-s2.0-0034977009
05
38Adverse effects of imipramine are increased by interaction with ASA in depressed patientsCoautor: Lares-Asseff I., Juárez-Olguín H., Jung-Cook H., Flores-Pérez J.2000NEUROPSYCHOPHARMACOLOGYScopus-id: 2-s2.0-0033991320
01
39Relationship between clinical and biologic variables and chloramphenicol pharmacokinetic parameters in pediatric patients with sepsis2ᵒ autor: Lares-Asseff I., Lugo Goytia G., Pérez Guillé M.G., Guillé Pérez A., et al.2000ANN PHARMACOTHERScopus-id: 2-s2.0-0343384261
06
40Influence of nutritional status on the pharmacokinetics of acetylsalicylic acid and its metabolites in children with autoimmune disease1ᵉʳ autor: Lares-Asseff I., Flores-Pérez J., Juárez-Olguín H., Ramírez-Lacayo M., et al.1999AMERICAN JOURNAL OF CLINICAL NUTRITIONWoS-id: 000078198000023
Scopus-id: 2-s2.0-0344609736
1212
41Evaluation on the performance of a bayesian adaptive control system to forecast the chloramphenicol serum concentrations in pediatric patients with sepsis and malnutrition [Prediccion bayesiana de las concentraciones sericas de cloranfenicol1ᵉʳ autor: Lares-Asseff I., Lugo-Goytia G., Pérez-Guillé M.G., Ortíz B.P., et al.1999REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATIONWoS-id: 000082026800003
Scopus-id: 2-s2.0-0032804391
24
42Dose-effect of the administration of ferrous fumarate in aged persons with iron deficiency [Dosis efecto de la administración de fumarato ferroso en personas ancianas con deficiencia de hierro.]1ᵉʳ autor: Lares-Asseff I., Pérez M.G., López M.C., Romero L., et al.1999REVISTA DE GASTROENTEROLOGIA DE MEXICOScopus-id: 2-s2.0-19244384737
03
43Plasmatic levels of theophylline in asthmatic patients. Comparative evaluations of two different methodsCoautor y autor de correspondencia: Lares-Asseff I., Juarez-Olguin H., Flores-Perez J.1998Archives Of Medical ResearchWoS-id: 000072854500007
Scopus-id: 2-s2.0-0031900405
12
44Bayesian pharmacokinetics of cefuroxime in critically ill septic children [Farmacocinética Bayesiana de cefuroxima en niños infectados gravemente enfermos]1ᵉʳ autor: Lares-Asseff I., Lugo-Goytía G., Pérez-Guillé M.G., Flores-Pérez J., et al.1998REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATIONWoS-id: 000076718500006
Scopus-id: 2-s2.0-0032128774
23
45Pharmacokinetics of cyclosporin as a function of energy-protein deficiency in children with chronic renal failure1ᵉʳ autor: Lares-Asseff I., Zaltzman S., Ferez Guillé G., Murguía T., et al.1998Proceedings of the Western Pharmacology SocietyScopus-id: 2-s2.0-33748197417
00
46Pharmacokinetics of cyclosporine as a function of energy-protein deficiency in children with chronic renal failure1ᵉʳ autor: Lares-Asseff I., Zaltzman S., Pérez Guillé M.G., Camacho G.A., et al.1997JOURNAL OF CLINICAL PHARMACOLOGYScopus-id: 2-s2.0-0030939645
06
47Bacterial mutagens in the urine of patients under tinidazole treatmentCoautor: Lares-Asseff I., Espinosa-Aguirre J.J., De La Torre R.A., Rubio J., et al.1996Mutation Research/environmental Mutagenesis And Related SubjectsWoS-id: A1996UA03800006
Scopus-id: 2-s2.0-0029879061
78
48Kinetic effects of trimethoprim-sulfamethoxazole in children with biliary atresia: A new dosing regimen1ᵉʳ autor: Lares-Asseff I., Villegas F., Perez G., Toledo A., et al.1996Archives Of Medical ResearchWoS-id: A1996UR31800014
Scopus-id: 2-s2.0-0030000169
23
49Genotoxic effects of metronidazoleCoautor: Lares I., Elizondo G., Gonsebatt M.E., Salazar A.M., et al.1996Mutation Research/genetic ToxicologyScopus-id: 2-s2.0-0030582451
3651
50Pharmacokinetics principles of the drug excretion in human breast milk [PRINCIPIOS FARMACOCINETICOS DE LA EXCRECION DE MEDICAMENTOS EN LA LECH MATERNA]2ᵒ autor y autor de correspondencia: Lares Asseff I., Belmont Gomez A.1995Acta Pediatrica EspanolaScopus-id: 2-s2.0-0028933709
00
51Nutritional state of beta-carotene and retinol in institutionalized elderly individuals of Mexico City1ᵉʳ autor: Lares-Asseff I., Del Carmen Lopez Hernandez M., Porras P.S., Ramirez Lopez E., et al.1995INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCHWoS-id: A1995TN15700003
Scopus-id: 2-s2.0-0029201316
11
52Trimethoprim/sulfamethoxazole kinetics in children with biliary atresia [4]1ᵉʳ autor: Lares-Asseff I., Villegas F., Perez-Guille G., Toledo A., et al.1994ANN PHARMACOTHERScopus-id: 2-s2.0-0028327011
00
53Trimethoprim/sulfamethoxazole kinetics in children with biliary atresia.1ᵉʳ autor: Lares-Asseff I., Villegas F., Pérez-Guillé G., Toledo A., et al.1994ANN PHARMACOTHERScopus-id: 2-s2.0-0028395467
01
54Antimutagenicity of cyclohexanol towards 4-(N-nitrosomethylamino)-1-(3-pyridil)-1-butanone and N-nitrosodiethylamine in Salmonella typhimurium strain TA100Coautor: Lares I., Espinosa-Aguirre J.J., Vilchis C., Ostrosky-Wegman P., et al.1993Mutation Research/genetic ToxicologyWoS-id: A1993LN81400002
Scopus-id: 2-s2.0-0027169553
98
55A new dosing regimen for metronidazole in malnourished children1ᵉʳ autor: Lares-Asseff I., Cravioto J., Santiago P., Pérez-Ortíz B.1993SCAND J INFECT DISWoS-id: A1993KQ45500018
Scopus-id: 2-s2.0-0027456392
715
56Pharmacokinetics of metronidazole in severely malnourished and nutritionally rehabilitated children1ᵉʳ autor: Lares-Asseff I., Cravioto J., Santiago P., Pérez-Ortíz B.1992CLIN PHARMACOL THERWoS-id: A1992HA81700006
Scopus-id: 2-s2.0-0026544342
2628
57Methotrexate pharmacokinetics in children with acute lymphoblastic leukemia1ᵉʳ autor: Lares-Asseff I., Paredes R., Taboada C., Cravioto J., et al.1988BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICOScopus-id: 2-s2.0-0023697579
00
58Antipyrine pharmacokinetic in malnourished children during the acute stage and after nutritional rehabilitation1ᵉʳ autor: Lares-Asseff I., Del Pilar Santiago-Porras M., Perez-Ortiz B., Cravioto J.1988BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICOScopus-id: 2-s2.0-0023949050
01
59Pharmacokinetics of antipyrine in grade III malnourished children during the acute phase and recovery [Farmacocinética de la antipirina en niños desnutridos de tercer grado durante la etapa aguda y en su recuperación.]1ᵉʳ autor: Lares-Asseff I., Santiago-Porras M.P., Pérez-Ortiz B., Cravioto J.1988BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICOScopus-id: 2-s2.0-0024009899
00
60Ampicillin pharmacokinetics in renal donors and transplanted children1ᵉʳ autor: Lares-Asseff I., Angel Jimenez M., Guzman A., Cravioto J., et al.1988BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICOScopus-id: 2-s2.0-18544407769
00
61Pharmacokinetics of ampicillin in anephric children without and during hemodialysis and in normal subjects [Farmacocinética de la ampicilina en niños anéfricos sin y durante la hemodiálisis y en sujetos normales.]1ᵉʳ autor: Lares-Asseff I., Jimenez M.A., Guzman A., Zaltman S., et al.1987BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICOScopus-id: 2-s2.0-0023444899
01
62Proposal of guidelines for the estimation of ethical risk in research protocols involving humans [Propuesta de un instrumento guía para la estimación del riesgo ético en los protocolos de investigación en la que participan seres humanos.Coautor: Lares-Asseff I., Castilla-Serna L., Jurado-García E., Ruíz-Maldonado R., et al.1986GACETA MEDICA DE MEXICOScopus-id: 2-s2.0-17044457199
01
63Double blind study of milk lactose intolerance in a group of rural and urban childrenCoautor: Lares I., Lisker R., Aguilar L., Cravioto J.1980AMERICAN JOURNAL OF CLINICAL NUTRITIONWoS-id: A1980JR10000020
Scopus-id: 2-s2.0-0019311098
1812
64Synergistic interaction between 4-allyl-1-hydroxy-2-methoxybenzene (eugenol) and diclofenac: An isobolograpic analysis in Wistar ratsCoautor: Lares-Asseff I., González-Lugo O.E., Pozos-Guillén A., Ponce-Peña P., et al.DRUG DEVELOPMENT RESEARCHScopus-id: 2-s2.0-85088794391
03